Eocene Ltd. (EOCN)

Eocene Ltd. (EOCN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.8M; returns 1 day -1.5%, 1 week +6.3%.

EoCene Ltd. (NASDAQ: EOCN), formerly known as Galmed Pharmaceuticals Ltd., is a clinical-stage biopharmaceutical and medical technology company focused on developing solutions for gastrointestinal (GI) disease management, GI oncology, and postoperative colorectal care. The company's platform spans both drug development and specialized medtech devices following its acquisition of Colospan Ltd.

Groups EOCN belongs to

• Recent Reverse Splits
• Israel Companies
• Biotechnology
• Clinical Stage Biopharma
• Clinical Stage
• Medical Devices
• Gastroenterology
• Biopharmaceutical
• Liver Disease
• NASH
• Oncology

EOCN financial model: income statement, cash flow and balance sheet